Loading...
•
Mar 31
Cellebrite Q1 2025 Earnings Report
Cellebrite reported strong Q1 2025 results with 20% revenue growth and a significant improvement in profitability.
Key Takeaways
Cellebrite saw solid revenue growth driven by a 21% increase in subscription revenue, alongside improved profitability and strong ARR momentum.
Revenue grew 20% year-over-year to $107.5M.
ARR reached $408M, a 23% increase.
Adjusted EBITDA margin expanded to 22%.
GAAP net income improved to $17.4M from a prior loss.
Cellebrite
Cellebrite
Cellebrite Revenue by Segment
Revenue by Segment
Subscription Services Revenue
CapyFin.comTerm License Revenue
CapyFin.comOther Non-Recurring Revenue
CapyFin.comProfessional Services Revenue
CapyFin.com Forward Guidance
Cellebrite expects continued top-line growth and margin expansion, with ARR and adjusted EBITDA targets unchanged, though full-year revenue expectations were revised slightly due to lower one-time revenue forecasts.
Positive Outlook
- ARR forecast raised to $480M–$495M for FY2025.
- Q2 ARR guidance in the range of $416M–$426M.
- Q2 adjusted EBITDA expected between $26M–$28M.
- Full-year adjusted EBITDA maintained at $113M–$123M.
- Focus on global diversification and integrated portfolio expansion.
Challenges Ahead
- Full-year revenue guidance slightly reduced.
- Lower anticipated one-time professional services revenue.
- U.S. Federal spending environment remains constrained.
- Increased reliance on second-half bookings for FY targets.
- Operating margin still trails non-GAAP levels due to costs.
Revenue & Expenses
Visualization of income flow from segment revenue to net income